GPT and metabolic syndrome: The prevalence of MetS was significantly higher among study participants with a low AST/ALT ratio of 93 /224(41.5%) in comparison to the prevalence observed among those with a high AST/ALT ratio of 40/153 (26.1%), with a p-value of 0.002.